Major pharmaceutical firms fare ill in 1Q

Published: 2012-04-18 07:00:00

Updated: 2012-04-18 07:00:00

Korea's major drug firms performed worse in the first quarter of 2012 than three months earlier largely due to quick handling of their drug inventories to soften the impact from the government-mandated cuts in drug prices, data showed Monday.

According to the data compiled by brokerage houses,...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK